Drug Profile
Tretinoin - Ortho Dermatologics
Alternative Names: All-trans retinoic acid; RAM 0.08%; Renova; Retin-A Micro; RetinovaLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Ortho-McNeil
- Developer Ortho Dermatologics
- Class Antiacnes; Antineoplastics; Cyclohexenes; Keratolytics; Retinoids; Small molecules
- Mechanism of Action Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Acne; Photodamage
Most Recent Events
- 27 Jul 2017 Valeant Pharmaceuticals International acquired Ortho Dermatologics in 2011 and changed the name of the later to Valeant Dermatology. Subsequently, in July 2017, it was rebranded to Ortho Dermatologics
- 31 Jan 2014 Registered for Acne in USA (Topical, 0.08% microsphere gel)
- 08 Jul 2010 Efficacy data from a clinical study comparing two treatment regimens in Acne released by Ortho Dermatologics